Minireviews
Copyright ©The Author(s) 2021.
World J Gastroenterol. Aug 28, 2021; 27(32): 5341-5350
Published online Aug 28, 2021. doi: 10.3748/wjg.v27.i32.5341
Table 1 Summary of studies on differential diagnosis of hepatocellular carcinoma
Ref.
Aim of the study
Modality
Patients
Method
AUC of the final model
Nie et al[7]Differentiation between HCC and HCACT131MLT: 0.96, V: 0.94
Nie et al[8]Differentiation between HCC and FNHCT156MLT: 0.979, V: 0.917
Mokrane et al[9]Differentiation between HCC and non-HCC nodulesCT178MLT: 0.70, V: 0.66
Ponnoprat et al[10]Differentiation between HCC and ICC CT257MLNA
Shi et al[11]Differentiation of HCC from other FLLsCT342DL0.925
Yasaka et al[12]Liver mass classificationCT560DL0.92
Cao et al[13]FLL classificationCT375DLV: 0.88-0.99
Jiang et al[14]Comparing the diagnostic accuracies of EASL (v2018), LI-RADS criteria, and radiomics models for HCCMRI211MLT: 0.861, V: 0.810
Zhen et al[15]Classification of liver tumorsMRI1411DL0.963-0.998
Liu et al[16]Differentiation of cHCC-CC from CC and HCCMRI85ML0.77
Huang et al[17]Diagnosis of DPHCC MRI100ML0.784
Jian et al[18]Characterization of HCCMRI112DLNA
Wu et al[19]Classification of HCC and hepatic hemangiomaMRI369MLT: 0.86, V: 0.89